This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
TECVAYLI® (teclistamab-cqyv)
Medical Information
TALVEY® (talquetamab-tgvs)
Last Updated: 07/07/2026
SUMMARY
- Johnson & Johnson does not recommend any practices, procedures, or usage that deviate from the product labeling or are not approved by the regulatory agencies.
A prescriber has ordered TECVAYLI and/or TALVEY for a patient. What is required from the Pharmacy/Healthcare Setting? - Prior to dispensing, the pharmacy or healthcare setting must identify if the prescription is written by a prescriber who has not had a TECVAYLI or TALVEYprescription filled by the pharmacy or healthcare setting before through the processes and procedures established as a requirement of the REMS.
- For prescriptions written by a prescriber who has not had a TECVAYLI or TALVEY prescription filled by the pharmacy or healthcare setting before: Obtain authorization to dispense by contacting the REMS Program to verify the prescriber is certified.
- This can be done by contacting the REMS Coordinating Center (1-855-810-8064) or within the TECVAYLI and TALVEY REMS portal (www.TEC-TALREMS.com).
PRODUCT LABELING
- TECVAYLI (teclistamab-cqyv) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.; https://www.jnjlabels.com/package-insert/product-monograph/prescribing-information/TECVAYLI-pi.pdf.
- TALVEY (talquetamab-tgvs) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.; https://www.jnjlabels.com/package-insert/product-monograph/prescribing-information/TALVEY-pi.pdf.
Would you like to clear and leave your conversation? Message history will be lost.